Page last updated: 2024-09-03

rhenium-186 hedp and durapatite

rhenium-186 hedp has been researched along with durapatite in 1 studies

Compound Research Comparison

Studies (rhenium-186 hedp)	Trials (rhenium-186 hedp)	Recent Studies (post-2010) (rhenium-186 hedp)	Studies (durapatite)	Trials (durapatite)	Recent Studies (post-2010) (durapatite)
75	32	19	17,101	522	7,832

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Mabhouh, AA; Mercer, JR	1

Other Studies

1 other study(ies) available for rhenium-186 hedp and durapatite

Article	Year
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7 Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2008

Article

Year

188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.

European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7

Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution

2008